Zai Lab Limited (ZLAB) Launches Hong Kong Secondary Listing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Zai Lab Launches Hong Kong Secondary Listing
September 16, 2020 7:15 AM EDTSHANGHAI and SAN FRANCISCO, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Zai Lab Limited (Zai Lab or the Company) (NASDAQ: ZLAB), an innovative commercial stage biopharmaceutical company, today announced the launch of its Hong Kong public offering (the Hong Kong Public Offering), which forms part of the global offering (the Offering) of 10,564,050 new ordinary shares (the Offer Shares or Shares) and listing of its ordinary shares on the Main Board of The Stock Exchange of Hong Kong Limited (the Hong Kong Stock Exchange) under the stock code 9688.
The Companys American depositary shares (ADSs), each representing one (1)Â ordinary share of the Company,... More
